RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/18947996http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18947996http://www.w3.org/2000/01/rdf-schema#comment"We have developed a first generation of hybrid sparsomycin-linezolid compounds into a new family of orally bioavailable biaryloxazolidinones that have activity against both linezolid-susceptible and -resistant gram-positive bacteria as well as the fastidious gram-negative bacteria Haemophilus influenzae and Moraxella catarrahalis. The convergent synthesis of these new compounds is detailed."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.org/dc/terms/identifier"doi:10.1016/j.bmcl.2008.10.011"xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Chen S."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Chen Y."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Goldberg J."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Wang D."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Wu Y."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Zhou J."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Johnson G."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Ippolito J.A."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Bhattacharjee A."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Springer D."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Tran J."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Farmer J."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Duffy E."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Hanselmann R."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Lou R."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Orbin A."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Oyelere A."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/author"Salvino J."xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/name"Bioorg Med Chem Lett"xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/pages"6175-6178"xsd:string
http://purl.uniprot.org/citations/18947996http://purl.uniprot.org/core/title"Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics."xsd:string